Clinical Trials on School Drop Out Prevention in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
- United States Department of Defense (DOD)
- Iyad Naeem Muhammad, PhD
- Oblikue Consulting
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- University of Applied Sciences Jena
- Foshan Sanshui District People's Hospital
- Paulo Sérgio Gomes Nogueira Borges
- Sudimplant SAS - Groupe TBR
- Gunkang Pharmaceuticals, Inc
- Lilly PharmaceuticalCompany
- S-Biotek Holding ApS
- Julian Taylor Green
- Korea Otsuka International Asia Arab
- Plethora Solutions Ltd
- Rivierduinen, Centre for Personality disorders Jelgersma
- Eurotrials Brasil Consultores Cientificos Ltda
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Arsha Vidya Tirtha
- View Full List
Medical Conditions
- Gray Platelet Syndrome
- Anemia Acute
- Huntington Chorea
- Advance Directive Completion
- Vibration; Exposure
- Testicular Teratoma
- Brain Tumor, Primary
- Blepharospasm of Both Eyelids
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Serum Albumin Low
- Immunologically-induced Lung Disease
- Malaria,Falciparum
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Visual Attention Span Deficit
- Thyroid and Parathyroid Surgery
- Puberty, Delayed
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Hypothermia Following Anesthesia, Sequela
- Chemotherapy-Induced Neutropenia
- Deformity Flexion
- View Full List
Drug Interventions
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Standard medical therapy
- Bimatoprost 0.03% eye drops
- Oxycodone
- Acalabrutinib in combination with VR
- Rovalpituzumab tesirine
- Vosaroxin
- F520
- MMV390048 120mg
- Sorafenib
- Cytisine
- Cyanoacrylate
- Pegfilgrastim
- Celecoxib
- S-Adenosyl-Methionine
- Mineralocorticoid receptor antagonist
- Ebselen
- ABY-035 i.v.
- Furmonertinib 160 mg
- Pemetrexed
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Gambia
- Contract Research Organizations in Georgia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Japan
- Contract Research Organizations in Suriname
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Uzbekistan
- CRO list by country